Mariotto and her colleagues established an in vitro hypoxia-resistant breast cancer model and demonstrated that cycling hypoxic/re-oxygenation stress selected out a CD44+CD24−ESA+ subpopulation with sphere-forming capacity, which was sufficiently identified as BCSCs. The gene discussed is CD44; the disease is breast cancer.